CICM Fellowship interactive diagrams
47 interactive teaching figures mapped to 35 CICM Fellowship learning objectives. Each diagram opens inside the matching note in Primex.
Section cvs
Cardiogenic shock and low cardiac output — haemodynamic profile, inotropes and mechanical support
-
Frank-Starling curve + Nephron + diuretic sites + Renin-angiotensin-aldosterone system — Manage low cardiac output states using pharmacological support (dobutamine, milrinone, levosimendan) and mechanical circulatory support; describe criteria for escalation to cardiac transplantation or LVAD bridge
Haemodynamic monitoring and vasopressor pharmacology — PA catheter, PiCCO, echo, noradrenaline, vasopressin
-
CICMF_CVS_7 Frank-Starling curveFrank-Starling curve — Describe the pharmacology and clinical indications for vasopressors (noradrenaline, vasopressin, metaraminol, phenylephrine) and inotropes (adrenaline, dobutamine, milrinone); and outline the approach to refractory vasod…
Section resp
ARDS and lung-protective ventilation — Berlin definition, PEEP titration, prone positioning
-
Lung + chest wall compliance (Campbell diagram) + Mechanical ventilation modes — Apply the Berlin definition of ARDS; describe lung-protective ventilation (low tidal volume 6 ml/kg PBW, plateau pressure <30 cmH2O, PEEP titration using PEEP-FiO2 tables) and the evidence from ARDSNet; and outline rescu…
-
CICMF_RESP_3 Mechanical ventilation modesMechanical ventilation modes — Describe the mechanisms of ventilator-induced lung injury (barotrauma, volutrauma, atelectrauma, biotrauma); apply strategies to minimise VILI in clinical practice; and outline the pathophysiology of dynamic hyperinflati…
Mechanical ventilation — modes, settings, patient-ventilator dyssynchrony and VILI
-
CICMF_RESP_2 Mechanical ventilation modesMechanical ventilation modes — Select and apply modes of mechanical ventilation (VC-AC, PC-AC, PRVC, SIMV, PSV); adjust ventilator settings based on respiratory mechanics; and recognise and manage patient-ventilator dyssynchrony (double triggering, re…
Weaning from mechanical ventilation and non-invasive support — SBT, extubation, NIV, HFNO
-
CICMF_RESP_4 Mechanical ventilation modesMechanical ventilation modes — Apply a systematic approach to weaning from mechanical ventilation including daily spontaneous breathing trials (T-piece vs PSV), extubation readiness assessment (RSBI, cough strength, secretion management) and post-extu…
-
CICMF_RESP_5 Mechanical ventilation modesMechanical ventilation modes — Describe the evidence base for non-invasive ventilation (CPAP, BiPAP) in acute hypercapnic respiratory failure (COPD), cardiogenic pulmonary oedema and immunocompromised patients; and outline criteria for NIV failure and…
ECMO — VV vs VA, anticoagulation, circuit management, weaning
-
CICMF_RESP_6 Coagulation cascadeCoagulation cascade — Describe the circuit configuration of venovenous (VV-ECMO) and venoarterial (VA-ECMO) ECMO; manage the anticoagulation strategy (heparin, ACT, anti-Xa targets); and outline the approach to ECMO weaning and decannulation
-
CICMF_RESP_11 Oxygen cascade — atmosphere to mitochondrionOxygen cascade — atmosphere to mitochondrion — Apply the physical principles of ECMO: oxygenator gas exchange (sweep gas governs CO2 clearance; blood flow and FdO2 govern O2 delivery), recirculation in VV-ECMO (definition, measurement, mitigation), pre- vs post-membr…
Severe asthma, COPD exacerbation, VAP and pleural disease in ICU — ventilation, bronchodilators, prevention bundles, chest drain
-
CICMF_RESP_7 Mechanical ventilation modesMechanical ventilation modes — Manage severe asthma in the ICU including inhalational bronchodilators, IV salbutamol, IV magnesium, ketamine and the principles of ventilation in status asthmaticus (permissive hypercapnia, high PEEP limitation)
-
CICMF_RESP_10 Mechanical ventilation modesMechanical ventilation modes — Manage COPD exacerbation in the ICU including controlled oxygen therapy (target SpO2 88–92%), nebulised bronchodilators, systemic corticosteroids, NIV (BiPAP) and the management of dynamic hyperinflation on mechanical ve…
Section renal
Acute kidney injury and renal replacement therapy — KDIGO staging, CRRT, IHD
-
CICMF_RENAL_1 Nephron + diuretic sites + Acute kidney injury stagingNephron + diuretic sites + Acute kidney injury staging — Apply the KDIGO AKI staging criteria in the ICU; differentiate pre-renal, intrinsic renal (ATN, GN, interstitial nephritis) and post-renal causes; and outline the principles of AKI management including fluid optimisation…
-
CICMF_RENAL_2 Coagulation cascade + Acute kidney injury stagingCoagulation cascade + Acute kidney injury staging — Compare the modalities of CRRT (CVVH, CVVHD, CVVHDF) with intermittent haemodialysis; prescribe CRRT (dose, fluid balance, anticoagulation — systemic heparin vs regional citrate); and describe the criteria for RRT cessat…
Sodium, potassium and electrolyte disorders in ICU — hyponatraemia, hyperkalaemia
-
Nephron + diuretic sites + Renin-angiotensin-aldosterone system — Apply a systematic approach to hyponatraemia and hypernatraemia in the ICU; diagnose and manage SIADH (fluid restriction, vasopressin antagonists); and describe the management of central and nephrogenic diabetes insipidu…
-
Nephron + diuretic sites + Renin-angiotensin-aldosterone system — Manage life-threatening hyperkalaemia in the ICU (calcium gluconate, insulin-dextrose, salbutamol, sodium bicarbonate, RRT) and hypokalaemia (replacement rate, ECG monitoring); and apply the approach to refractory hypoka…
Acid-base disorders and mineral metabolism — metabolic acidosis, Stewart approach, calcium/phosphate
-
CICMF_RENAL_5 Davenport acid-base diagram + Anion gap and delta ratioDavenport acid-base diagram + Anion gap and delta ratio — Apply the Henderson-Hasselbalch equation to complex acid-base disorders; use the Stewart approach (SID, SIG, ATot) where appropriate; and diagnose and manage metabolic acidosis (anion gap, delta ratio, normal AG) and alk…
Fluid management and nephrotoxic AKI prevention — fluid responsiveness, contrast nephropathy
-
CICMF_RENAL_8 Acute kidney injury stagingAcute kidney injury staging — Apply strategies to prevent contrast-associated AKI (volume expansion, N-acetylcysteine, iso-osmolar contrast); describe the management of aminoglycoside and vancomycin nephrotoxicity; and outline cisplatin and amphoteri…
Section neuro
Traumatic brain injury and spinal cord injury — ICP management, CPP targets, autonomic dysreflexia
-
CICMF_NEURO_1 Cerebral autoregulation (CBF vs MAP / PaCO₂ / PaO₂) + Monro-Kellie intracranial volume + ICP curveCerebral autoregulation (CBF vs MAP / PaCO₂ / PaO₂) + Monro-Kellie intracranial volume + ICP curve — Apply the BTF guidelines for severe traumatic brain injury; manage ICP using a tiered approach (HOB 30°, osmotherapy, CSF drainage, CRANIECTOMY); describe CPP targets; and outline multimodal monitoring (ICP, PbtO2, TCD, …
Subarachnoid haemorrhage and intracerebral haemorrhage — vasospasm, nimodipine, blood pressure targets
-
CICMF_NEURO_4 Cerebral autoregulation (CBF vs MAP / PaCO₂ / PaO₂) + Monro-Kellie intracranial volume + ICP curveCerebral autoregulation (CBF vs MAP / PaCO₂ / PaO₂) + Monro-Kellie intracranial volume + ICP curve — Manage spontaneous intracerebral haemorrhage in the ICU including reversal of coagulopathy, blood pressure targets (INTERACT2 data), surgical decompression criteria and ICP management
Guillain-Barré syndrome, brain death, delirium and neuromuscular complications — ICU neuropathy, organ donation
-
CICMF_NEURO_7 Spirometry — V-t + flow-volume loopSpirometry — V-t + flow-volume loop — Manage Guillain-Barré syndrome in the ICU including respiratory monitoring (FVC, NIF thresholds for intubation), IVIG vs plasmapheresis; and describe critical illness polyneuropathy and myopathy recognition and managemen…
Section haem
DIC, HIT and thrombotic microangiopathies — ISTH scoring, 4T score, TTP/HUS, plasmapheresis
-
CICMF_HAEM_1 Coagulation cascadeCoagulation cascade — Diagnose DIC using ISTH scoring (platelets, PT, fibrinogen, D-dimer, soluble fibrin monomers); describe the management of bleeding DIC (FFP, cryoprecipitate, platelets) and thrombotic DIC; and distinguish from other caus…
-
CICMF_HAEM_2 Coagulation cascadeCoagulation cascade — Apply the 4T score for HIT type 2; confirm with PF4-heparin antibody ELISA and serotonin release assay; describe cessation of heparin and initiation of alternative anticoagulation (argatroban, danaparoid, fondaparinux); …
Massive transfusion and anticoagulation in ICU — MTP, ROTEM/TEG, heparin, DOACs, reversal agents
-
CICMF_HAEM_5 Coagulation cascadeCoagulation cascade — Describe the anticoagulation strategy in the ICU including unfractionated heparin (infusion, APTT monitoring), LMWH dosing in CKD, DOACs and reversal agents (idarucizumab, andexanet alfa, PCC); and outline anticoagulatio…
Haematological malignancy and blood product therapy in ICU — neutropenic fever, tumour lysis, transfusion thresholds
-
CICMF_HAEM_7 Iron homeostasisIron homeostasis — Apply BCSH guidelines for blood product transfusion in critically ill patients; describe the restrictive transfusion strategy (TRICC trial, Hb threshold 70 g/L); and manage acute haemolytic transfusion reactions, TRALI a…
Section endo
DKA, HHS and glucose management in ICU — fixed-rate insulin, NICE-SUGAR targets, hypoglycaemia
-
CICMF_ENDO_1 Glucose homeostasisGlucose homeostasis — Manage DKA in the ICU (ADS (Australian Diabetes Society) / eTG adult DKA protocol: fixed rate IV insulin 0.1 units/kg/hr, NS resuscitation, potassium replacement); describe the management of HHS (slower correction, antic…
-
CICMF_ENDO_2 Glucose homeostasisGlucose homeostasis — Apply the NICE-SUGAR trial glucose targets (6–10 mmol/L) in ICU; describe continuous insulin infusion protocols; and manage hypoglycaemia as a healthcare complication
Adrenal insufficiency and thyroid emergencies — CIRCI, hydrocortisone, thyroid storm, myxoedema coma
-
CICMF_ENDO_3 Hypothalamic-pituitary-adrenal axisHypothalamic-pituitary-adrenal axis — Diagnose critical illness-related corticosteroid insufficiency (CIRCI) using random cortisol and the cosyntropin test; describe the hydrocortisone dosing regimen in vasopressor-dependent septic shock (APROCCHSS/ADRENAL t…
Section trauma
Damage control resuscitation and traumatic brain injury — haemostatic resuscitation, ICP management
-
CICMF_TRAUMA_2 Cerebral autoregulation (CBF vs MAP / PaCO₂ / PaO₂) + Monro-Kellie intracranial volume + ICP curveCerebral autoregulation (CBF vs MAP / PaCO₂ / PaO₂) + Monro-Kellie intracranial volume + ICP curve — Manage severe TBI in ICU applying BTF guidelines: ICP < 22 mmHg, CPP 60–70 mmHg, tier 1 (HOB, sedation, normocapnia) to tier 3 (barbiturate coma, decompressive craniectomy) interventions; and interpret multimodal neuromo…
Burns, rhabdomyolysis and polytrauma — Parkland formula, inhalation injury, compartment syndrome
-
CICMF_TRAUMA_6 Acute kidney injury stagingAcute kidney injury staging — Describe the pathophysiology, diagnosis and management of rhabdomyolysis (forced diuresis, urinary alkalinisation, haemodialysis for refractory hyperkalaemia); and outline crush syndrome management in mass casualty incid…
Section tox
Opioid, CCB and beta-blocker toxicity — naloxone, high-dose insulin, lipid rescue, VA-ECMO
-
CICMF_TOX_4 Glucose homeostasisGlucose homeostasis — Manage calcium channel blocker and beta-blocker toxicity in the ICU using high-dose insulin euglycaemic therapy (1–10 U/kg/hr), lipid rescue emulsion (intralipid), vasopressors, glucagon and VA-ECMO as rescue
Section obsicu
Sepsis in pregnancy, amniotic fluid embolism and physiological changes — antibiotic selection, DIC, pharmacokinetics
-
CICMF_OBSICU_3 Lung volumes & capacities + Mechanical ventilation modesLung volumes & capacities + Mechanical ventilation modes — Describe the physiological adaptations of pregnancy relevant to ICU care (increased CO, reduced FRC, altered drug pharmacokinetics, hypercoagulable state) and their implications for mechanical ventilation and drug dosing
Section sedation
Neuromuscular blockade in ICU — indications, train-of-four monitoring, ICU-acquired weakness
-
CICMF_SEDATION_3 Train-of-four monitoringTrain-of-four monitoring — Describe the indications for neuromuscular blockade in the ICU (ventilator dyssynchrony, severe ARDS — ACURASYS data, tetanus, ICP management); outline train-of-four monitoring; and describe the management of ICU-acquire…
NMB monitoring and complications — train-of-four, agent choice, ACURASYS/ROSE, ICU-acquired weakness
-
CICMF_SEDATION_7 Train-of-four monitoringTrain-of-four monitoring — Describe neuromuscular blockade monitoring and complications — train-of-four with a peripheral nerve stimulator (target T1–T2 of 4), choice of agent (cisatracurium vs rocuronium, reversal with sugammadex), depth of paral…
Section pharmicu
Vasopressor pharmacology and drug dosing in organ failure — noradrenaline, vasopressin, renal/hepatic dose adjustment
-
CICMF_PHARMICU_3 Acute kidney injury stagingAcute kidney injury staging — Apply dose adjustment principles for renally cleared drugs in AKI and during CRRT; describe drugs requiring hepatic dose reduction; and apply the principles of drug dosing during ECMO (increased Vd for lipophilic drugs, …
Section special
Hyperthermia syndromes and electrical injury in ICU — heat stroke, NMS, MH, rhabdomyolysis, fasciotomy
-
CICMF_SPECIAL_4 Acute kidney injury stagingAcute kidney injury staging — Manage electrical and lightning injury in the ICU including mandatory cardiac monitoring, management of rhabdomyolysis and AKI, fasciotomy for compartment syndrome; and describe the delayed presentations
Primex
Open these diagrams inside CICM Fellowship
The diagrams above are interactive — they live inside the per-learning-objective notes in Primex. The full CICM Fellowship curriculum, MCQ library, AI-graded SAQ and viva practice are bundled in the same subscription.
Start 7-day free trial